11 January 2024 in Journal for ImmunoTherapy of Cancer
Background The response rate to immune checkpoint inhibitors targeting programmed cell death 1 (PD-1) receptor is 13%–18% for patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). Detailed understanding of the tumor immune microenvironment (TIME) is crucial in order to explain and improve this response rate. HNSCCs arise at various anatomical locations including the oral cavity, hypopharynx, larynx and oropharynx. Studies directly comparing immune infiltration between anatomical sites are scarce. Since the distinct locations could drive deviating microenvironments, we questioned whether the immune composition varies across these HNSCC sites. Methods Here, we characterized the TIME of 76 fresh tumor specimens using flow cytometry and performed single-cell RNA-sequencing on nine head and neck tumor samples. Results We found major differences in the composition of the TIME between patients. When comparing anatomical sites: tumors originating from the oral cavity had higher T cell infiltrates than tumors from other anatomical sites. The percentage of tumor-infiltrating T-lymphocytes positive for the immune checkpoint PD-1 varied considerably between patients, with the highest fraction of PD-1+ T cells found in larynx squamous cell carcinomas (SCCs). While we had hypothesized that the anatomical sites of tumor origin would drive sample clustering, our data showed that the type of TIME was more dominant and was particularly driven by the fraction of T cells positive for PD-1. Moreover, a high proportion of PD-1+ CD8+ T cells associated with an improved overall survival. Using single-cell RNA-sequencing, we observed that PD-1 expression was highest in the CD8-ENTPD1 tissue resident memory T cell/exhausted T cell and CD4-CXCL13 type 1 T helper cell clusters. Conclusions We found that oral cavity SCCs had the highest frequencies of T cells. We also observed considerable interpatient heterogeneity for PD-1 on T cells, with noticeably higher frequencies of PD-1+ CD4+ T helper cells in larynx SCCs. Within the entire cohort, a higher fraction of CD8+ T cells positive for PD-1 was linked to improved overall survival. Whether the fraction of PD-1+ T cells within the TIME enables immune checkpoint inhibitor response prediction for patients with head and neck cancer remains to be determined.
8 September 2026 in Scientific Data
High-throughput omics technologies enable detailed molecular profiling of complex microbial communities, yet FAIRification of the resulting datasets is commonly treated as a secondary step performed after data analysis. This approach overlooks the practical benefits of integrating standardized metadata early in the research process: experimental conditions directly determine how raw data should be processed, so capturing interoperable metadata at the outset creates a machine-actionable basis for driving and documenting the entire analytical workflow. Here, we describe a modular, containerized workflow implemented in Common Workflow Language that follows the single-containment principle and records software provenance, tool versions, and parameter settings at each processing step. Using defined mock metagenomic community datasets as controlled benchmarks, we demonstrate how machine-readable experimental metadata can initiate and parameterize multi-step analyses covering read quality control, assembly, binning, quality assessment, and functional annotation. The resulting provenance chains link experimental context, workflow definitions, and derived data products to support traceability and downstream reuse.
24 December 2025 in bioRxiv
Background: Molecular profiling using high-throughput omics technologies has tremendously increased our ability to interrogate complex microbial communities at the molecular level. In the context of data reuse, the FAIRification of these extensive datasets is frequently perceived as a secondary administrative task, addressed only after data analysis has been completed. However, this approach overlooks the potential benefits of early metadata integration as the procedures for processing and analyzing raw data are primarily dictated by the underlying research design and experimental conditions. Gathering interoperable research metadata at the earliest stages creates a standardized basis for managing, processing, and analyzing data enabling more efficient and reproducible FAIR workflows. Results: The single containment principle was used to develop modular containerized reproducible workflows that support the FAIR principles for research software by systematically capturing standardized metadata for each data processing step along with the resulting data products. Using defined mock metagenomic datasets as an example, we show that interoperable research metadata can be used to drive such computational workflows. By processing raw data accordingly, machine-actionable provenance chains are created that enhance the reproducibility and reusability of the resulting data products. Conclusions: A seamless integration of wet lab experiments with computational investigations is essential for a FAIR end-to-end research process. Meta-data-managed workflows prevent the need for unnecessary data manipulation. Workflow provenance registration explicates the complex multi-step methods employed for data processing and analysis. Combining FAIR principles with data provenance registration enhances the reusability of omics datasets by promoting transparency and reproducibility.